Trump has financial interest in French company that owns brand name hydroxychloroquine drug

[Maddox]

If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.

Trump’s Aggressive Advocacy of Malaria Drug for Treating Coronavirus Divides Medical Community (Published 2020)

While Dr. Anthony Fauci has urged caution in using hydroxychloroquine, some doctors are prescribing it to patients who have the virus despite the fact it has never been tested for it.

www.nytimes.com